SYVC

Synovics Pharmaceuticals, Inc. SYVC

SYVC
Synovics Pharmaceuticals, Inc. CMRA
Comera Life Sciences Holdings, Inc. SNNAQ
Sienna Biopharmaceuticals, Inc. GBIM
GlobeImmune, Inc. RBSH
Rebus Holdings, Inc. NLVVF
New Leaf Ventures Inc NTII
Neurobiological Technologies, Inc. ANTH
Anthera Pharmaceuticals, Inc. COTQF
Cotinga Pharmaceuticals Inc. TNGNQ
Tengion, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode SYVC CMRA SNNAQ GBIM RBSH NLVVF NTII ANTH COTQF TNGNQ
6M 0.00 % -50.00 % 0.00 % -80.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 900.00 %
YTD 0.00 % -50.00 % 0.00 % -50.00 % -50.00 % -97.84 % 0.00 % -50.00 % 0.00 % 900.00 %
1Y 0.00 % -50.00 % 0.00 % -50.00 % 0.00 % -96.77 % 0.00 % -50.00 % 0.00 % 900.00 %
3Y 0.00 % -99.99 % 0.00 % -85.71 % -98.73 % -99.91 % 0.00 % 0.00 % 900.00 % 9 900.00 %
5Y 0.00 % -100.00 % -98.44 % -99.97 % -99.98 % -99.96 % -93.33 % -99.54 % -95.35 % 9 900.00 %
10Y 0.00 % -100.00 % -100.00 % -100.00 % -100.00 % -99.98 % -99.44 % -100.00 % -99.96 % 9 900.00 %
Depuis le début 0.00 % -100.00 % -100.00 % -100.00 % -100.00 % -99.98 % -100.00 % -100.00 % -99.98 % 9 900.00 %

Dividende

Neurobiological Technologies, Inc.